cmvcrv.wiki • Professional Insights • Expert Commentary • Resource Center
cmvcrv.wiki

New Details,Psoriasin

Unveiling the Multifaceted Role of Psoriasin: An Antimicrobial Peptide in Skin Health and Disease oleh T Takahashi·2020·Dirujuk 148 kali—Antimicrobial psoriasin (S100A7) protects human skin from antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide.

:peptide

A
Danielle Sanchez

covers '' industry developments and changes with consistent information sharing on YouTube and TikTok

Published on

Executive Summary

antimicrobial oleh T Takahashi·2020·Dirujuk 148 kali—Antimicrobial psoriasin (S100A7) protects human skin from antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide.

Psoriasin, also known by its protein designation S100A7, stands as a significant player in the body's defense mechanisms, particularly within the skin. This antimicrobial peptide is not merely a passive component but an active modulator of the skin's innate immunity, exhibiting potent microbicidal properties and influencing cellular processes critical for maintaining skin integrity. Research has illuminated its fundamental role as a principal E. coli-killing antimicrobial protein, released by epithelial cells to combat bacterial threats.

The scientific exploration into psoriasin (S100A7) has revealed its remarkable versatility. Beyond its direct antimicrobial action, it functions as a multifunctional modulator. Studies have demonstrated that psoriasin exerts pore-forming activity at pH values below 6, a mechanism that directly disrupts microbial membranes, thereby contributing to its efficacy against a range of pathogens. This characteristic is crucial for understanding how psoriasin contributes to skin protection.

Furthermore, antimicrobial psoriasin (S100A7) actively participates in skin barrier function. It has been shown to enhance the expression of keratinocyte differentiation markers and strengthens the skin's tight junction barrier. This means that psoriasin not only fights off invaders but also helps to build and maintain the physical fortifications of the skin, preventing unwanted substances from entering.

The expression of psoriasin is not static; it is influenced by various physiological and pathological conditions. For instance, research indicates that psoriasin is upregulated in conditions like atopic dermatitis and following experimental skin barrier disruption. This suggests that the body increases its production of this antimicrobial peptide when the skin barrier is compromised or challenged.

A significant area of research focuses on the involvement of psoriasin in inflammatory skin conditions, most notably psoriasis. In psoriatic skin, there is an excessive production of antimicrobial peptides and proteins (AMPs), and psoriasin is among these prominently expressed molecules. The overexpression of antimicrobial peptides and proteins (AMPs) such as human β-defensin-2 (hBD2), LL37, and psoriasin has frequently been observed in lesional skin of psoriasis patients. These antimicrobial peptides are not just defensive but can also act as “alarmins” or DAMPs to stimulate immune cells and initiate inflammatory cascades. This dual role of psoriasin in both defense and inflammation highlights the complexity of its function in skin pathology.

The connection between psoriasis and antimicrobial peptides is a growing field of study. While psoriasin plays a role in the innate immune system's response, other antimicrobial peptides like cathelicidin (LL-37) are also implicated in the development and progression of psoriasis. The intricate interplay of these peptides contributes to the chronic inflammation characteristic of the disease.

Moreover, psoriasin is not solely confined to skin defense. Its role has also been investigated at the ocular surface and in the lacrimal apparatus, suggesting a broader protective function within mucosal tissues. The antimicrobial peptide has also been studied in the context of diabetes, where it was found that diabetes downregulates the antimicrobial peptide, psoriasin, potentially impacting the skin's susceptibility to infections in diabetic individuals.

Topical formulations containing psoriasin are available, such as Psoriasin 1.25% topical gel and Psoriasin Deep Moisturizing Ointment - 2% Coal Tar. These products aim to leverage the properties of psoriasin to manage symptoms associated with psoriasis. They are designed to slow the rapid growth of skin cells, decrease scaling, relieve itching, and help prevent recurrence, ultimately aiming to stop the itching, scaling, and redness that comes with psoriasis.

In summary, psoriasin (S100A7) is a vital antimicrobial peptide with a crucial role in skin defense and barrier function. Its ability to directly combat microbes, modulate inflammation, and strengthen the skin's structural integrity makes it a significant molecule in dermatology. While its antimicrobial properties are well-established, ongoing research continues to unravel its complex interactions within the skin's immune system and its implications in various dermatological conditions, including psoriasis. The investigation into the expression and antimicrobial role of psoriasin continues to yield valuable insights into maintaining healthy skin.

Related Articles

Frequently Asked Questions

Here are the most common questions about .

Psoriasin (S100A7) is a principal antimicrobial peptide of
Chrysin alleviates imiquimod-induced psoriasis-like skin
The antimicrobial protein psoriasin (S100A7) is
oleh R Gläser·2009·Dirujuk 267 kali—The antimicrobial protein psoriasin (S100A7)is upregulated in atopic dermatitisand after experimental skin barrier disruption J Invest Dermatol. 2009 Mar; 

Leave a Comment

Share your thoughts, feedback, or additional insights on this topic.

Explore More